Training and guidance covering similar points as mentioned elsewhere in this section could be developed for other stakeholders involved in trials, for example Chief Investigators, oversight committee members, sponsor representatives or patient contributors.
This could focus on their particular roles and what is expected of them in preparing for and managing participation changes.
Patient contributors can play a particularly important role in ensuring proposed methods for handling participation changes are suitable (see General Considerations).
Guidance for contributors could refer to specific elements they might advise on, such as ensuring trials are as burden-free as possible from participants from the outset, advising on ways participants could continue participating with less commitment (see principle D1 – protecting study integrity by design) and on what should happen if trial staff and participants lose contact with one another (see principle O4 – losing contact).